NO147186B - PROCEDURE FOR PREPARING SUBSTITUTED PURINE COMPOUNDS - Google Patents
PROCEDURE FOR PREPARING SUBSTITUTED PURINE COMPOUNDS Download PDFInfo
- Publication number
- NO147186B NO147186B NO772959A NO772959A NO147186B NO 147186 B NO147186 B NO 147186B NO 772959 A NO772959 A NO 772959A NO 772959 A NO772959 A NO 772959A NO 147186 B NO147186 B NO 147186B
- Authority
- NO
- Norway
- Prior art keywords
- mixture
- hydroxyethoxymethyl
- acid
- filtered
- added
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 6
- 150000003212 purines Chemical class 0.000 title description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 6
- 230000001476 alcoholic effect Effects 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims description 3
- 150000003139 primary aliphatic amines Chemical class 0.000 claims description 3
- 150000004703 alkoxides Chemical class 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 150000005619 secondary aliphatic amines Chemical class 0.000 claims description 2
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 239000000203 mixture Substances 0.000 description 24
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 12
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 12
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 238000010992 reflux Methods 0.000 description 8
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- VBHLKZHSCMQLTI-UHFFFAOYSA-N 2-[(2-acetamido-6-oxo-3h-purin-9-yl)methoxy]ethyl acetate Chemical compound N1C(NC(=O)C)=NC(=O)C2=C1N(COCCOC(C)=O)C=N2 VBHLKZHSCMQLTI-UHFFFAOYSA-N 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- 239000012065 filter cake Substances 0.000 description 5
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical group N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- ONSWVOSXVUHESJ-UHFFFAOYSA-N 2-(hydroxymethoxy)ethanol Chemical compound OCCOCO ONSWVOSXVUHESJ-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- QNXFUWFRTWSSOK-UHFFFAOYSA-N n-acetyl-n-(6-oxo-3,7-dihydropurin-2-yl)acetamide Chemical compound O=C1NC(N(C(C)=O)C(=O)C)=NC2=C1NC=N2 QNXFUWFRTWSSOK-UHFFFAOYSA-N 0.000 description 3
- -1 phenyl- Chemical group 0.000 description 3
- WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 description 2
- XFEQOLXBMLXKDE-UHFFFAOYSA-N 2-(acetyloxymethoxy)ethyl acetate Chemical compound CC(=O)OCCOCOC(C)=O XFEQOLXBMLXKDE-UHFFFAOYSA-N 0.000 description 2
- JXBPYDQBIDJOPX-UHFFFAOYSA-N 2-[(2,6-diacetamidopurin-9-yl)methoxy]ethyl acetate Chemical compound C(C)(=O)NC1=NC(=C2N=CN(C2=N1)COCCOC(C)=O)NC(C)=O JXBPYDQBIDJOPX-UHFFFAOYSA-N 0.000 description 2
- CSMCRCLIPQDIKB-UHFFFAOYSA-N 2-[(2,6-diaminopurin-9-yl)methoxy]ethanol Chemical compound NC1=NC(N)=C2N=CN(COCCO)C2=N1 CSMCRCLIPQDIKB-UHFFFAOYSA-N 0.000 description 2
- MSSXOMSJDRHRMC-UHFFFAOYSA-N 9H-purine-2,6-diamine Chemical compound NC1=NC(N)=C2NC=NC2=N1 MSSXOMSJDRHRMC-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 239000003443 antiviral agent Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 150000005690 diesters Chemical class 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- UPSLZTCOOLWRMD-UHFFFAOYSA-N 1-(1,2,2,3-tetraacetyl-7H-purin-4-yl)ethanone Chemical compound C(C)(=O)C12N(C(N(C=C2NC=N1)C(C)=O)(C(C)=O)C(C)=O)C(C)=O UPSLZTCOOLWRMD-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241000450599 DNA viruses Species 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 208000000903 Herpes simplex encephalitis Diseases 0.000 description 1
- 208000037018 Herpes simplex virus encephalitis Diseases 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 208000005100 Herpetic Keratitis Diseases 0.000 description 1
- 241001135569 Human adenovirus 5 Species 0.000 description 1
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- KLUTVBXWIFFOPM-UHFFFAOYSA-N N-(6-amino-7H-purin-2-yl)formamide Chemical compound C(=O)NC1=NC(=C2NC=NC2=N1)N KLUTVBXWIFFOPM-UHFFFAOYSA-N 0.000 description 1
- MVSVCUQNNJMHKV-UHFFFAOYSA-N N-acetyl-N-[9-acetyl-2-(diacetylamino)purin-6-yl]acetamide Chemical compound C(C)(=O)N(C1=NC(=C2N=CN(C2=N1)C(C)=O)N(C(C)=O)C(C)=O)C(C)=O MVSVCUQNNJMHKV-UHFFFAOYSA-N 0.000 description 1
- OHLUUHNLEMFGTQ-UHFFFAOYSA-N N-methylacetamide Chemical compound CNC(C)=O OHLUUHNLEMFGTQ-UHFFFAOYSA-N 0.000 description 1
- 206010073938 Ophthalmic herpes simplex Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 241000700618 Vaccinia virus Species 0.000 description 1
- 206010046865 Vaccinia virus infection Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- MHSVUSZEHNVFKW-UHFFFAOYSA-N bis-4-nitrophenyl phosphate Chemical compound C=1C=C([N+]([O-])=O)C=CC=1OP(=O)(O)OC1=CC=C([N+]([O-])=O)C=C1 MHSVUSZEHNVFKW-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 201000010884 herpes simplex virus keratitis Diseases 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 208000007089 vaccinia Diseases 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Description
Foreliggende oppfinnelse angår en fremgangsmåte for The present invention relates to a method for
syntese av substituerte purinforbindelser, da spesielt 9-(2-hydroksyetoksy-metyl)-derivater av purinene 2-amino-adenin og guanin. synthesis of substituted purine compounds, especially 9-(2-hydroxyethoxymethyl) derivatives of the purines 2-amino-adenine and guanine.
9-(2-hydroksyetoksymetyl)-derivatene av puriner har antiviral aktivitet mot forskjellige typer av DNA- ogRNA-virus, The 9-(2-hydroxyethoxymethyl) derivatives of purines have antiviral activity against various types of DNA and RNA viruses,
både i in vitro og in vivo eksperimenter. Spesielt er disse forbindelser aktive som antivirale midler mot adenovirus, så som adenovirus 5 og rhinovirus. De er spesielt aktive som et anti-viralt middel mot vaccinia og herpes virus, så som simplex, both in vitro and in vivo experiments. In particular, these compounds are active as antiviral agents against adenoviruses, such as adenovirus 5 and rhinovirus. They are particularly active as an anti-viral agent against vaccinia and herpes viruses, such as simplex,
zoster og varicella hos pattedyr, og slike virus frembringer sykdommer som herpetic keratitis hos kaniner og herpetic encephalitis hos mus. zoster and varicella in mammals, and such viruses produce diseases such as herpetic keratitis in rabbits and herpetic encephalitis in mice.
Eksempler på 9-(2-hydroksyetoksymetyl)-derivater av Examples of 9-(2-hydroxyethoxymethyl) derivatives of
puriner som viser spesielt god antiviral aktivitet, er 9-(2-hydroksyetoksymetyl)-guanin og 2-amino-9-(2-hydroksyetoksymetyl)-adenin. purines that show particularly good antiviral activity are 9-(2-hydroxyethoxymethyl)-guanine and 2-amino-9-(2-hydroxyethoxymethyl)-adenine.
Det er kjent en rekke fremgangsmåter for fremstilling av 9-(2-hydroksyetoksymetyl)-derivater av purin, f.eks. kan de fremstilles ved å fjerne en beskyttende gruppe fra 2-stillingen på sidekjeden. Alternativt kan de fremstilles ved å omdanne 2-og/eller 6-substituenter på .purinringen til en annen substituent (se britisk patent nr. 1.523.865). A number of methods are known for the production of 9-(2-hydroxyethoxymethyl) derivatives of purine, e.g. they can be prepared by removing a protecting group from the 2-position of the side chain. Alternatively, they can be prepared by converting 2- and/or 6-substituents on the purine ring to another substituent (see British Patent No. 1,523,865).
Man har nå funnet at visse 9-(2-hyrdoksyetoksymetyl)-derivater av puriner kan fremstilles ved en ny og fordelaktig syntesevei. Foreliggende oppfinnelse tilveiebringer således en fremgangsmåte for fremstilling av forbindelser med formel I: It has now been found that certain 9-(2-hyrdoxyethoxymethyl) derivatives of purines can be prepared by a new and advantageous synthesis route. The present invention thus provides a method for the preparation of compounds of formula I:
hvor R er amino eller hydroksy; som innbefatter at man i nærvær av en base hydrolyserer en forbindelse med formel II: 1 2 hvor R er hydroksy eller -NR • 1 2 og X og X er de samme eller forskjellige, og hver kan representere en alkyl eller fenyl-. 2 gruppe, og R er hydrogen eller where R is amino or hydroxy; which includes, in the presence of a base, hydrolyzing a compound of formula II: 1 2 where R is hydroxy or -NR • 1 2 and X and X are the same or different, and each may represent an alkyl or phenyl-. 2 group, and R is hydrogen or
forutsatt at når R er provided that when R is
hydroksy, så er R hydrogen. Når X og X er alkylgrupper, så har de fortrinnsvis fra 1 til 4 karbonatomer, fortrinnsvis er de av samme type og hver representerer en metylgruppe. hydroxy, then R is hydrogen. When X and X are alkyl groups, they preferably have from 1 to 4 carbon atoms, preferably they are of the same type and each represents a methyl group.
Den base som brukes under hydrolysen kan være en vandig eller alkoholisk primær eller sekundær alifatisk amin, et alkoksyd i alkohol, eller en vandig eller et alkoholisk hydroksyd, f.eks. natriumalkoksyd eller hydroksyd, og den foretrukne base er et vandig, primært alifatisk amin, f.eks. vandig metylamin. Av-hengig av den base som brukes, kan hydrolysen utføres ved tempera-turer fra romtemperatur og opp til den temperatur man finner på et dampbad. Generelt er det slik at jo lavere reaksjonstempera-tur, jo lengre vil reaksjonstiden være, men til gjengjeld får man færre sidereaksioner. The base used during the hydrolysis may be an aqueous or alcoholic primary or secondary aliphatic amine, an alkoxide in alcohol, or an aqueous or alcoholic hydroxide, e.g. sodium alkoxide or hydroxide, and the preferred base is an aqueous primary aliphatic amine, e.g. aqueous methylamine. Depending on the base used, the hydrolysis can be carried out at temperatures from room temperature up to the temperature found in a steam bath. In general, the lower the reaction temperature, the longer the reaction time will be, but in return you get fewer side reactions.
Et mellomprodukt med formelen II hvor R er An intermediate of formula II wherein R is
og hvor R<2> er kan fullstendig hydrolyseres i et trinn, f.eks. ved å bruke vandig metylamin. Alternativt og mer fordelaktig, kan mellomproduktet med formel II deacyleres i 2 trinn, i det første trinnet vil man fjerne en enkel gruppe fra 2- og 6-stillingene på purinringen ved mild hydrolyse ved romtemperatur ved at man f.eks. bruker butylamin i en lavere alkohol. Det annet trinn i hydrolysen, dvs. for å fjerne de gjenværende and where R<2> is can be completely hydrolyzed in one step, e.g. using aqueous methylamine. Alternatively and more advantageously, the intermediate product of formula II can be deacylated in 2 steps, in the first step a simple group will be removed from the 2 and 6 positions on the purine ring by mild hydrolysis at room temperature by e.g. uses butylamine in a lower alcohol. The second step in the hydrolysis, i.e. to remove the remaining ones
utføres ved å bruke sterkere baser, performed using stronger bases,
f.eks. vandig metylamin. e.g. aqueous methylamine.
Mellomproduktene med formel II er nye og kan fremstilles ved å omsette guanin eller 2-aminoadenin hvor 2 og 9, eller 2, 6 og 9-stillingene, respektivt er acylert, med en diester av 2-oksa-l,4-butandiol i nærvær av en katalytisk mengde av en sterk syre, f.eks. svovelsyre, sulfonsyre så som p-toluensulfonsyre, metansulfonsyre eller trifluormetansulfonsyre, sul-faminsyre, bis-(p-nitrofenyl)fosfat eller polyfosforsyre. The intermediates of formula II are new and can be prepared by reacting guanine or 2-aminoadenine where the 2 and 9, or 2, 6 and 9 positions, respectively, are acylated, with a diester of 2-oxa-1,4-butanediol in the presence of a catalytic amount of a strong acid, e.g. sulfuric acid, sulfonic acid such as p-toluenesulfonic acid, methanesulfonic acid or trifluoromethanesulfonic acid, sulfamic acid, bis-(p-nitrophenyl)phosphate or polyphosphoric acid.
Det acylerte purin kan på sin side igjen fremstilles ved The acylated purine can in turn be produced by
å omsette et passende purin med et syreanhydrid så som edikksyreanhydrid, eller et annet acyleringsmiddel, f.eks. et syrehalogenid. reacting a suitable purine with an acid anhydride such as acetic anhydride, or another acylating agent, e.g. an acid halide.
For å fremstille diesteren av 2-oksa-l,4-butandiol, To prepare the diester of 2-oxa-1,4-butanediol,
kan dioksolan omsettes med et syreanhydrid i nærvær av en katalytisk mengde av en sterk syre, f.eks. av den type som er angitt ovenfor. dioxolane can be reacted with an acid anhydride in the presence of a catalytic amount of a strong acid, e.g. of the type specified above.
De følgende eksempler illustrerer oppfinnelsen. The following examples illustrate the invention.
Eksempel 1 - 9-( 2- hydroksyetoksymetyl) guanin Example 1 - 9-(2-hydroxyethoxymethyl)guanine
En blanding av 120 g edikksyreanhydrid, 15 g edikksyre og 5,0 g p-toluensulfonsyre ble avkjølt til 10°C, og 70 g dioksolan ble tilsatt under røring og avkjøling ved en slik hastighet at temperaturen i blandingen ikke oversteg 40°C. Blandingen ble så avkjølt til romtemperatur, og 300 ml toluen og 50 g diacetylguanin ble tilsatt. Reaksjonsblandingen ble så oppvarmet til koking under tilbakeløp i 16 timer. Den ble så avkjølt til romtemperatur og 50 ml kloroform ble tilsatt og det faste produkt fjernet ved filtrering. Filterkaken ble vasket med kloroform og tørket for.dannelse av 2-acetamido-9-(2-acetoksymetyl)hypo-xantin. Den tørkede filterkaken ble tilsatt 350 ml 40% vandig metylamin, og blandingen oppvarmet under koking med tilbakeløp i 40 minutter, så avkjølt og filtrert. Filtratet ble fordampet under redusert trykk til en tykk suspensjon. Denne ble avkjølt og filtrert og filterkaken ble vasket med etanol og tørket, hvorved man fikk 27 g 9-(2-hydroksyetoksymetyl)guanin, renhet større enn 90%, smeltepunkt 255-257°C, utbyttet = 56%. A mixture of 120 g of acetic anhydride, 15 g of acetic acid and 5.0 g of p-toluenesulfonic acid was cooled to 10°C, and 70 g of dioxolane was added with stirring and cooling at such a rate that the temperature of the mixture did not exceed 40°C. The mixture was then cooled to room temperature, and 300 ml of toluene and 50 g of diacetylguanine were added. The reaction mixture was then heated to reflux for 16 hours. It was then cooled to room temperature and 50 ml of chloroform was added and the solid product removed by filtration. The filter cake was washed with chloroform and dried to give 2-acetamido-9-(2-acetoxymethyl)hypoxanthine. The dried filter cake was added to 350 ml of 40% aqueous methylamine, and the mixture heated under reflux for 40 minutes, then cooled and filtered. The filtrate was evaporated under reduced pressure to a thick suspension. This was cooled and filtered and the filter cake was washed with ethanol and dried, thereby obtaining 27 g of 9-(2-hydroxyethoxymethyl)guanine, purity greater than 90%, melting point 255-257°C, yield = 56%.
Eksempel 2 - 9-( 2- hydroksyetoksymetyl) guanin Example 2 - 9-(2-hydroxyethoxymethyl)guanine
En blanding av 50 g diacetylguanin, 59,8 g 2-oksa-l,4-butandiol og 1,2 g p-toluensulfonsyre i 350 ml toluen ble oppvarmet under røring og koking med tilbakeløp i 16 timer. Blandingen ble avkjølt til romtemperatur, filtrert hvoretter filterkaken ble vasket med toluen for dannelse av 2-acetamido-9-(2-ace-toksyetoksymetyl)-hypoxantin. Den ble så tørket og tilsatt 350 ml 40% vandig metylamin. Blandingen ble oppvarmet under koking med tilbakeløp i 40 minutter, avkjølt til romtemperatur og filtrert. Filtratet ble fordampet under redusert trykk til en tykk suspensjon. Denne ble tilsatt 200 ml etanol og det hele ble avkjølt, filtrert og vasket med etanol og tørket, hvorved man fikk 36 g 9-(2-hydroksyetoksymetyl)guanin, mer en 90% rent, utbyttet = 75%. A mixture of 50 g of diacetylguanine, 59.8 g of 2-oxa-1,4-butanediol and 1.2 g of p-toluenesulfonic acid in 350 ml of toluene was heated with stirring and refluxed for 16 hours. The mixture was cooled to room temperature, filtered, after which the filter cake was washed with toluene to give 2-acetamido-9-(2-ace-toxyethoxymethyl)-hypoxanthine. It was then dried and 350 ml of 40% aqueous methylamine was added. The mixture was heated under reflux for 40 minutes, cooled to room temperature and filtered. The filtrate was evaporated under reduced pressure to a thick suspension. To this was added 200 ml of ethanol and the whole was cooled, filtered and washed with ethanol and dried, thereby obtaining 36 g of 9-(2-hydroxyethoxymethyl)guanine, more than 90% pure, yield = 75%.
Eksempel 3 - 2- acetamido- 9-( 2- acetyloksyetoksymetyl) hypozantin Example 3 - 2-acetamido-9-(2-acetyloxyethoxymethyl) hypozantine
( fremstilling av utgangsmateriale) (production of starting material)
En blanding av 1,0 g diacetylguanin, 0,82 g 2-oksa-l,4-butandioldiacetat og 23 mg p-toluensulfonsyre i 4 g mineralolje ble holdt på 115°C under omrøring med redusert trykk over natten. Mineraloljen.ble så avhelt. Resten ble behandlet med kloroform og så ekstrahert med kokende metanol. Metanolekstraktet ble konsentrert til 50 ml, avkjølt og filtrert. Filtratet ble fordampet til tørrhet, hvorved man fikk 0,43 g faststoff. Dette ble renset ved kolonnekromatografi (silisiumdioksydgel, 10 g i kloroform eluert med 1:1 kloroform:aceton), hvoretter man fikk en omkrystallisering fra etanol og fikk 0,14 g 2-acetamido-9-(2-acetyloksyetoksymetyl)hypoxantin, smeltepunkt 202,5-204,5°C. A mixture of 1.0 g of diacetylguanine, 0.82 g of 2-oxa-1,4-butanediol diacetate and 23 mg of p-toluenesulfonic acid in 4 g of mineral oil was kept at 115°C under reduced pressure stirring overnight. The mineral oil was then poured off. The residue was treated with chloroform and then extracted with boiling methanol. The methanol extract was concentrated to 50 ml, cooled and filtered. The filtrate was evaporated to dryness, whereby 0.43 g of solid was obtained. This was purified by column chromatography (silica gel, 10 g in chloroform eluted with 1:1 chloroform:acetone), after which a recrystallization from ethanol gave 0.14 g of 2-acetamido-9-(2-acetyloxyethoxymethyl)hypoxanthine, melting point 202, 5-204.5°C.
Eksempel 4 - 2- amino- 9-( 2- hydroksyetoksymetyl) adenin Example 4 - 2-amino-9-(2-hydroxyethoxymethyl)adenine
(a) 89,0 g 2-formamidoadenin ble plassert i en 5-liters kolbe utstyrt med en luftrører og en kjøler (CaCl2"tørkerør) som var tilsatt 4 1 edikksyreanhydrid. Blandingen ble kokt ved tilbake-løp og holdt under koking i 60 timer. Deretter ble overskuddet av anhydrid fjernet ved destillasjon ved atmosfæres trykk inntil man hadde fjernet ca. 3,5 1 destillat. Destillasjonen under redusert trykk ble fortsatt til man hadde fjernet mesteparten av (a) 89.0 g of 2-formamidoadenine was placed in a 5-liter flask equipped with an air stirrer and a condenser (CaCl2" drying tube) to which was added 4 L of acetic anhydride. The mixture was refluxed and kept under reflux for 60 hours. Then the excess of anhydride was removed by distillation at atmospheric pressure until about 3.5 liters of distillate had been removed. Distillation under reduced pressure was continued until most of the
det gjenværende anhydrid. Det mørke brune residuet var viskøst ved avkjøling til romtemperatur og ble oppløst i diklormetan. the remaining anhydride. The dark brown residue was viscous on cooling to room temperature and was dissolved in dichloromethane.
Det ble filtrert for å fjerne suspenderte faste stoffer, hvoretter oppløsningen ble fordampet i vakuum og man fikk 211,0 g (> 100%) av 2,6-bis-(diacetylamino)-9-acetylpurin. Utbyttet var 96,7% basert på nmr, og resten av materialet var edikksyreanhydrid. (b) 174 g penta-acetylpurin ble slått sammen med en 126,8 g 1,4-diacetoksy-2-oksabutan i en kolbe utstyrt med rører og tørke-rør. Blandingen ble plassert på et oljebad ved 130°C og rørt i et par minutter for å homogenisere blandingen. Syrekatalysatoren, dvs. 2,74 g para-toluensulfonsyre ble så tilsatt i en porsjon og oppvarmingen ble fortsatt i vakuum i 4 timer hvorved man da fikk en nesten kvantitativ omdannelse til produktene. Reaksjonsblandingen ble avkjølt til romtemperatur og lagret under tørr nitrogen. (c) Smelteproduktet (208,5 g) ble oppløst i etanol (5 ml/g) ved romtemperatur og overført til en kolbe utstyrt med en dråpe-trakt, rører og termometer. 14 0,4 g n-butylamin ble så dråpvis tilsatt iløpet av 2 timer, og den eksotermiske reaksjonen ble regulert ved hjelp av et vannbad. Maksimumstemperaturen som tillot reaksjonen gå til,var bare ca. 30°C. Produktet begynte å skille seg ut fra blandingen under selve tilsetningen. Etter at tilsetningen var ferdig, ble blandingen rørt ved romtemperatur i 3 timer og så plassert i et kaldt rom over natten. Produktet ble fjernet ved filtrering og man fikk en pasta-lignende masse som ble utrørt med 1 x 500 ml aceton og så igjen filtrert. Produktet ble tørket i vakuum ved 65°C i 3 timer og så ved romtemperatur over natten hvorved man fikk 154,2 g (91,7%) av et lyst brunt hardt fast stoff. Dette produkt ble renset ved at det ble oppløst i varm dimetylformamid (10 ml/g) ved 100-110°C slik at man fikk en ugjennomskinnelig brun oppløsning. Etter avkjøling over natten ved 5°C, ble produktet fjernet ved filtrering, vasket med 1 x 250 ml aceton og lufttørket, hvorved man fikk 121,7 g (78,8%) 2,6-diacetamido-9-(2-acetoksyetoksymetyl)purin. (d) 121,7 g 2,6-diacetamido-9-(2-acetoksyetoksymetyl)purin ble tilsatt en rørt oppløsning av vandig metylamin (608,5 ml av en 40% oppløsning) iløpet av 5 minutter. Tilsetningen ble fulgt av en mild eksotermisk reaksjon som hevet temperaturen på blandingen til 35°C og alt faststoff løste seg iløpet av et par minutter. Etter røring i 2 1/2 time, viste tynnsjiktskromato-grafi av blandingen at man hadde en fullstendig reaksjon. Blandingen ble så konsentrert i vakuum på et vannbad ved 4 5-50°C og man fikk en tykk masse av brune krystaller. Disse ble ut-rørt med 545 ml aceton i et kvarter for å fjenre N-metylacetamid og deretter vakuumfiltrert. Filterkaken ble vasket med aceton (1 x 200 ml) og lufttørket, hvorved man fikk 74,7 g (96,0%) It was filtered to remove suspended solids, after which the solution was evaporated in vacuo to give 211.0 g (> 100%) of 2,6-bis-(diacetylamino)-9-acetylpurine. The yield was 96.7% based on nmr, and the rest of the material was acetic anhydride. (b) 174 g of penta-acetylpurine was combined with 126.8 g of 1,4-diacetoxy-2-oxabutane in a flask equipped with a stirrer and drying tube. The mixture was placed in an oil bath at 130°C and stirred for a few minutes to homogenize the mixture. The acid catalyst, i.e. 2.74 g of para-toluenesulfonic acid, was then added in one portion and the heating was continued in vacuum for 4 hours, whereby an almost quantitative conversion to the products was then obtained. The reaction mixture was cooled to room temperature and stored under dry nitrogen. (c) The melt product (208.5 g) was dissolved in ethanol (5 ml/g) at room temperature and transferred to a flask equipped with a dropping funnel, stirrer and thermometer. 14 0.4 g of n-butylamine was then added dropwise over 2 hours, and the exothermic reaction was regulated by means of a water bath. The maximum temperature that allowed the reaction to proceed was only approx. 30°C. The product began to separate from the mixture during the actual addition. After the addition was complete, the mixture was stirred at room temperature for 3 hours and then placed in a cold room overnight. The product was removed by filtration and a paste-like mass was obtained which was stirred with 1 x 500 ml of acetone and then filtered again. The product was dried in vacuo at 65°C for 3 hours and then at room temperature overnight to give 154.2 g (91.7%) of a light brown hard solid. This product was purified by dissolving it in hot dimethylformamide (10 ml/g) at 100-110°C to give an opaque brown solution. After cooling overnight at 5°C, the product was removed by filtration, washed with 1 x 250 mL of acetone and air dried to give 121.7 g (78.8%) of 2,6-diacetamido-9-(2-acetoxyethoxymethyl ) purine. (d) 121.7 g of 2,6-diacetamido-9-(2-acetoxyethoxymethyl)purine was added to a stirred solution of aqueous methylamine (608.5 ml of a 40% solution) over 5 minutes. The addition was followed by a mild exothermic reaction which raised the temperature of the mixture to 35°C and all solids dissolved within a few minutes. After stirring for 2 1/2 hours, thin layer chromatography of the mixture showed complete reaction. The mixture was then concentrated in vacuo on a water bath at 45-50°C and a thick mass of brown crystals was obtained. These were stirred with 545 ml of acetone for fifteen minutes to remove N-methylacetamide and then vacuum filtered. The filter cake was washed with acetone (1 x 200 ml) and air dried, whereby 74.7 g (96.0%) were obtained
uren hydrert 2-amino-9-(2-hydroksyetoksymetyl)adenin som lyst brune krystaller. Disse ble tørket i vakuum ved 80°C i 18 timer, og man fikk 69,3 g (89,0%) tørt produkt. impure hydrogenated 2-amino-9-(2-hydroxyethoxymethyl)adenine as light brown crystals. These were dried in vacuum at 80°C for 18 hours, and 69.3 g (89.0%) of dry product was obtained.
Eksempel 5 Example 5
2-acetamido-9-(2-acetyloksyetoksymetyl)hypoxantin (6,19 g) ble suspendert i IN natriumhydroksyd (40 ml) og oppvarmet ved tilbakeløp i 1 time. Blandingen ble avkjølt, nøytralisert med 6N saltsyre og produktet frafiltrert. Det faste stoffet ble vasket med isvann (10 ml) og med aceton (15 ml) og tørket under vakuum natten over. Vekt 4,13 g (91,8%) av 9-(2-hydroksyetoksymetyl) guanin, smp. 255-257°C. 2-acetamido-9-(2-acetyloxyethoxymethyl)hypoxanthine (6.19 g) was suspended in 1N sodium hydroxide (40 mL) and heated at reflux for 1 hour. The mixture was cooled, neutralized with 6N hydrochloric acid and the product filtered off. The solid was washed with ice water (10 mL) and with acetone (15 mL) and dried under vacuum overnight. Weight 4.13 g (91.8%) of 9-(2-hydroxyethoxymethyl)guanine, m.p. 255-257°C.
Eksempel 6 Example 6
2-acetamido-9-(2-acetyloksyetoksymetyl)hypoxantin 2-acetamido-9-(2-acetyloxyethoxymethyl)hypoxanthine
(6,19 g) ble oppslemmet i en oppløsning av natriummetylat (3,24 g) i metanol (40 ml). Blandingen ble oppvarmet ved til-bakeløp i 1 time og fikk avkjøles. Iseddik (3,96 g) ble tilsatt og blandingen helt i vann (40 ml). Etter avkjøling, (6.19 g) was slurried in a solution of sodium methylate (3.24 g) in methanol (40 ml). The mixture was heated at reflux for 1 hour and allowed to cool. Glacial vinegar (3.96 g) was added and the mixture poured into water (40 ml). After cooling,
0°C, ble det resulterende bunnfall filtrert, vasket med kaldt vann (15 ml) og med aceton (15 ml) og tørket under vakuum og dette ga 4,03 g (89,6%) 9-(2-hydroksyetoksymetyl)guanin, 0°C, the resulting precipitate was filtered, washed with cold water (15 mL) and with acetone (15 mL) and dried under vacuum to give 4.03 g (89.6%) of 9-(2-hydroxyethoxymethyl)guanine ,
smp. 255-257°C. m.p. 255-257°C.
Eksempel 7 Example 7
2-acetamido-9- (2-acetyloksyetoksymetyl)hypoxantin 2-acetamido-9-(2-acetyloxyethoxymethyl)hypoxanthine
(6,19 g) ble tilsatt til en oppløsning av kaliumhydroksyd (3,96 g) i etanol (40 ml) og oppvarmet ved tilbakeløp i 1 (6.19 g) was added to a solution of potassium hydroxide (3.96 g) in ethanol (40 mL) and heated at reflux for 1
time. Blandingen fikk avkjøles og iseddik (3,96 g ) ble tilsatt. Blandingen ble helt i vann (40 ml) og 50 ml vann ble tilsatt. pH-verdien ble innstilt til 7,0 med vandig natriumhydroksyd og blandingen avkjølt med is-vann og filtrert. Det faste stoffet vasket med kaldt vann (20 ml) og med aceton (20 ml) hour. The mixture was allowed to cool and glacial acetic acid (3.96 g) was added. The mixture was poured into water (40 ml) and 50 ml of water was added. The pH was adjusted to 7.0 with aqueous sodium hydroxide and the mixture cooled with ice-water and filtered. The solid washed with cold water (20 ml) and with acetone (20 ml)
og tørket under vakuum og dette ga 4,0 g (88,9%) 9-(2-hydroksyetoksymetyl) guanin, smp. 255-257°C. and dried under vacuum to give 4.0 g (88.9%) of 9-(2-hydroxyethoxymethyl)guanine, m.p. 255-257°C.
Eksempel 8 Example 8
2-acetamido-9-(2-acetyloksyetoksymetyl)hypoxantin 2-acetamido-9-(2-acetyloxyethoxymethyl)hypoxanthine
(6,19 g) ble oppslemmet med trietylamin (5 g) og vann (40 ml) og blandingen oppvarmet ved tilbakeløp i 2 timer. Blandingen fikk avkjøles til 0°C og ble filtrert. Det faste stoffet ble vasket med vann (15 ml) og med aceton (15 ml) og tørket under vakuum og dette ga 4,34 g (96%) 9-(2-hydroksyetoksymetyl)guanin, smp. 255-257°C. (6.19 g) was slurried with triethylamine (5 g) and water (40 mL) and the mixture heated at reflux for 2 h. The mixture was allowed to cool to 0°C and was filtered. The solid was washed with water (15 ml) and with acetone (15 ml) and dried under vacuum to give 4.34 g (96%) of 9-(2-hydroxyethoxymethyl)guanine, m.p. 255-257°C.
Claims (2)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71810576A | 1976-08-27 | 1976-08-27 | |
US05/773,135 US4146715A (en) | 1975-08-27 | 1977-02-28 | 2-amido-9-(2-acyloxyethoxymethyl)hypoxanthines |
Publications (3)
Publication Number | Publication Date |
---|---|
NO772959L NO772959L (en) | 1978-02-28 |
NO147186B true NO147186B (en) | 1982-11-08 |
NO147186C NO147186C (en) | 1983-02-16 |
Family
ID=27109837
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO772959A NO147186C (en) | 1976-08-27 | 1977-08-26 | PROCEDURE FOR PREPARING SUBSTITUTED PURINE COMPOUNDS |
NO822502A NO150119C (en) | 1976-08-27 | 1982-07-20 | INTERMEDIATES FOR USE IN THE PREPARATION OF SUBSTITUTED PURINE COMPOUNDS |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO822502A NO150119C (en) | 1976-08-27 | 1982-07-20 | INTERMEDIATES FOR USE IN THE PREPARATION OF SUBSTITUTED PURINE COMPOUNDS |
Country Status (12)
Country | Link |
---|---|
AT (1) | AT357566B (en) |
CA (2) | CA1096863A (en) |
CH (1) | CH634843A5 (en) |
CS (1) | CS196384B2 (en) |
DD (1) | DD131856A6 (en) |
DK (1) | DK147857C (en) |
FI (1) | FI64160C (en) |
GB (1) | GB1567671A (en) |
NL (1) | NL7709458A (en) |
NO (2) | NO147186C (en) |
SE (2) | SE432764B (en) |
YU (1) | YU41079B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4880820A (en) * | 1983-06-24 | 1989-11-14 | Merck & Co., Inc. | Guanine derivatives |
US4918219A (en) * | 1983-10-31 | 1990-04-17 | Warner-Lambert Company | Glycerine derivatives |
IE842642L (en) * | 1983-10-31 | 1985-04-30 | Harvard College | Purine Derivatives |
YU45690B (en) * | 1984-12-22 | 1992-07-20 | Krka Tovarna Zdraviln.Sol.O. | PROCEDURE FOR PREPARING 9- (2-HYDROXYETHOXYMETHYL) -GUANINE |
DE3889248T2 (en) * | 1987-05-04 | 1994-11-17 | Kemijski Inst | Process for the preparation of purine compounds. |
EP0717744B1 (en) * | 1993-09-10 | 1997-05-07 | RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY | A process for the preparation of 9-(2-hydroxy)-ethoxymethyl-guanine |
DE19536164A1 (en) * | 1995-09-28 | 1997-04-03 | Boehringer Ingelheim Kg | Improved Process for the Production of 9 - [(2-Hydroxyethoxy) methyl] guanine (Acyclovir) |
IT1276126B1 (en) * | 1995-11-14 | 1997-10-27 | Archimica Spa | PROCEDURE FOR THE PREPARATION OF 9 - ((2-HYDROXYETHOXY) METHYL) GUANINE |
WO1997024357A1 (en) * | 1995-12-28 | 1997-07-10 | Mallinckrodt Chemical, Inc. | Process for synthesis and purification of a compound useful in the preparation of acyclovir |
-
1977
- 1977-08-24 YU YU2022/77A patent/YU41079B/en unknown
- 1977-08-26 GB GB35914/77A patent/GB1567671A/en not_active Expired
- 1977-08-26 CH CH1046677A patent/CH634843A5/en not_active IP Right Cessation
- 1977-08-26 DK DK380377A patent/DK147857C/en not_active IP Right Cessation
- 1977-08-26 SE SE7709606A patent/SE432764B/en not_active IP Right Cessation
- 1977-08-26 DD DD7700200760A patent/DD131856A6/en not_active IP Right Cessation
- 1977-08-26 NO NO772959A patent/NO147186C/en unknown
- 1977-08-26 NL NL7709458A patent/NL7709458A/en active Search and Examination
- 1977-08-26 FI FI772548A patent/FI64160C/en not_active IP Right Cessation
- 1977-08-26 CS CS775615A patent/CS196384B2/en unknown
- 1977-08-26 AT AT620177A patent/AT357566B/en not_active IP Right Cessation
- 1977-08-26 CA CA285,592A patent/CA1096863A/en not_active Expired
-
1980
- 1980-06-20 CA CA354,538A patent/CA1096864A/en not_active Expired
-
1982
- 1982-07-20 NO NO822502A patent/NO150119C/en unknown
-
1983
- 1983-08-23 SE SE8304549A patent/SE447113B/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA1096864A (en) | 1981-03-03 |
SE447113B (en) | 1986-10-27 |
SE7709606L (en) | 1978-02-28 |
DK380377A (en) | 1978-02-28 |
FI772548A (en) | 1978-02-28 |
NO147186C (en) | 1983-02-16 |
NO150119C (en) | 1984-08-22 |
FI64160B (en) | 1983-06-30 |
CS196384B2 (en) | 1980-03-31 |
ATA620177A (en) | 1979-12-15 |
YU202277A (en) | 1983-02-28 |
CA1096863A (en) | 1981-03-03 |
NL7709458A (en) | 1978-03-01 |
SE8304549L (en) | 1983-08-23 |
YU41079B (en) | 1986-12-31 |
NO150119B (en) | 1984-05-14 |
CH634843A5 (en) | 1983-02-28 |
SE432764B (en) | 1984-04-16 |
FI64160C (en) | 1983-10-10 |
DK147857C (en) | 1985-06-10 |
NO772959L (en) | 1978-02-28 |
DD131856A6 (en) | 1978-07-26 |
SE8304549D0 (en) | 1983-08-23 |
NO822502L (en) | 1978-02-28 |
GB1567671A (en) | 1980-05-21 |
AT357566B (en) | 1980-07-25 |
DK147857B (en) | 1984-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1883639B1 (en) | Preparation of famciclovir and other purine derivatives | |
CA2188181C (en) | Preparation of purines | |
NO152446B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 9-SUBSTITUTED HYPOXANTIN DERIVATIVES | |
NO147186B (en) | PROCEDURE FOR PREPARING SUBSTITUTED PURINE COMPOUNDS | |
AU613967B2 (en) | Process for the preparation of purine derivatives | |
US3501456A (en) | Arabinofuranosyl nucleosides and intermediates | |
CA1075237A (en) | Purine derivatives | |
Kaiwar et al. | Synthesis of 9-[cis-3-(hydroxymethyl) cyclobutyl]-adenine and-guanine | |
SU1454253A3 (en) | Method of producing 9-(2-oxyethoxymethyl) guanine | |
US6646125B1 (en) | Process for the synthesis of chloropurine intermediates | |
SU932991A3 (en) | Process for producing purine derivatives | |
EP0052959B1 (en) | Production of purine derivatives and intermediates therefor | |
CA1296001C (en) | 1-hydroxyalkylxanthines, processes for their preparation and medicaments containing them | |
CN109206465B (en) | Method for synthesizing adenosine cyclophosphate | |
PL108512B1 (en) | Method of producing purine derivatives | |
Detweiler et al. | Some Heterocyclic Secondary Amines1 | |
RU1809831C (en) | Method of dideoxynucleosides synthesis | |
US3317532A (en) | Derivatives of pyrimidine | |
Baker et al. | Synthesis of 6‐substituted pyrimidines by the wittig reaction. III. Via 2‐amino‐4‐hydroxy‐5‐phenylbutyl‐6‐pyrimidylmethyl triphenyl phosphonium bromide | |
Doak et al. | The reaction between diazonium fluoborates and antimony trichloride in organic solvents | |
DK142323B (en) | Process for the preparation of pyrimido (4,5-b) quinoline-4 (3H) -one-2-carboxylic acid alkyl esters. | |
Ghal et al. | An Efficient Synthesis of 2-[(4-Amino∼ 1, 2-dihyro-2-oxo-1-pyrimidinyl) methoxyi-l, 3-propanediyl-di-L-valinate an Anti-cytomegalovirus Agent | |
JPS5913800A (en) | Preparation of 9-(beta-d-arabinofuranosyl)adenine | |
MXPA97005480A (en) | Procedure to prepare penciclovir or famciclo | |
JPH03240788A (en) | New production of cyclobutane derivative and intermediate |